




Searching News Database: imaging agent
HSMN NewsFeed - 16 Oct 2024
Bracco Diagnostics Inc. and Subtle Medical Announce FDA Clearance of AiMIFY(TM) Software for Enhanced MRI
Bracco Diagnostics Inc. and Subtle Medical Announce FDA Clearance of AiMIFY(TM) Software for Enhanced MRI
HSMN NewsFeed - 23 Aug 2021
Lightpoint Medical and Telix Pharmaceuticals Announce Strategic Collaboration Agreement
Lightpoint Medical and Telix Pharmaceuticals Announce Strategic Collaboration Agreement
HSMN NewsFeed - 23 Jul 2021
ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
HSMN NewsFeed - 27 Jun 2019
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
HSMN NewsFeed - 16 May 2018
Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
HSMN NewsFeed - 18 Dec 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
HSMN NewsFeed - 3 Oct 2017
Aytu BioScience Announces International Distribution Agreement for Fiera(R) in Japan
Aytu BioScience Announces International Distribution Agreement for Fiera(R) in Japan
HSMN NewsFeed - 25 Sep 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for TAGITOL(TM) V (Barium Sulfate) Oral Suspension
Bracco Diagnostics Inc. Receives U.S. FDA Approval for TAGITOL(TM) V (Barium Sulfate) Oral Suspension
HSMN NewsFeed - 28 Jul 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) NECTAR (barium sulfate) Oral Suspension
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) NECTAR (barium sulfate) Oral Suspension
HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
HSMN NewsFeed - 25 Aug 2016
Mallinckrodt Receives FDA Fast-Track Designation for Synacthen(R) Depot IND Application
Mallinckrodt Receives FDA Fast-Track Designation for Synacthen(R) Depot IND Application
HSMN NewsFeed - 9 Jun 2016
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
Bradley Campbell, President and COO of Amicus Therapeutics, elected to Progenics Board of Directors
HSMN NewsFeed - 9 Feb 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
HSMN NewsFeed - 28 May 2014
Mallinckrodt Pharmaceuticals’ New Drug Application Accepted for Review by FDA
Mallinckrodt Pharmaceuticals’ New Drug Application Accepted for Review by FDA
HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
HSMN NewsFeed - 13 Jan 2014
Mallinckrodt Pharmaceuticals and Medtronic Announce Clinical and Commercial Collaboration
Mallinckrodt Pharmaceuticals and Medtronic Announce Clinical and Commercial Collaboration
HSMN NewsFeed - 20 Aug 2013
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC
HSMN NewsFeed - 21 Mar 2013
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
HSMN NewsFeed - 18 Jul 2012
Lantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International
Lantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International
HSMN NewsFeed - 5 Jun 2012
Former Pfizer Worldwide Business Development Director Joins Australian Drug Development Company Agenix
Former Pfizer Worldwide Business Development Director Joins Australian Drug Development Company Agenix
HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
HSMN NewsFeed - 18 Mar 2011
Lilly and Avid Receive Complete Response Letter from FDA for Amyvid (florbetapir F 18 injection)
Lilly and Avid Receive Complete Response Letter from FDA for Amyvid (florbetapir F 18 injection)
HSMN NewsFeed - 8 Feb 2011
Positron’s Attrius(R) PET Scanner Seeks Market Expansion into Neurologic Imaging
Positron’s Attrius(R) PET Scanner Seeks Market Expansion into Neurologic Imaging
HSMN NewsFeed - 21 Jan 2011
Lantheus Medical Imaging Announces New National Contract with Novation for ABLAVAR(R) and DEFINITY(R)
Lantheus Medical Imaging Announces New National Contract with Novation for ABLAVAR(R) and DEFINITY(R)
HSMN NewsFeed - 14 Jan 2011
GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease
GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease
HSMN NewsFeed - 17 Dec 2009
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
HSMN NewsFeed - 17 Nov 2009
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
HSMN NewsFeed - 31 Jul 2009
QuantRx(R) Forms Joint Venture with NuRx for the Global Launch of Innovative Point-of-Care Products
QuantRx(R) Forms Joint Venture with NuRx for the Global Launch of Innovative Point-of-Care Products
HSMN NewsFeed - 6 Jul 2009
Covidien Announces Health Canada Approval for its Generic Myocardial Perfusion Imaging Kit
Covidien Announces Health Canada Approval for its Generic Myocardial Perfusion Imaging Kit
HSMN NewsFeed - 30 Jun 2009
FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
HSMN NewsFeed - 31 Mar 2009
GE Healthcare Announces Data from Phase III Study of AdreView in Heart Failure Patients
GE Healthcare Announces Data from Phase III Study of AdreView in Heart Failure Patients
HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
HSMN NewsFeed - 22 Dec 2008
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
HSMN NewsFeed - 10 Dec 2008
ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software
ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software
HSMN NewsFeed - 3 Nov 2008
Covidien and PETNET Solutions Enter Co-Marketing Agreement for Nuclear Medicine Products
Covidien and PETNET Solutions Enter Co-Marketing Agreement for Nuclear Medicine Products
HSMN NewsFeed - 23 Sep 2008
Covidien Announces FDA Approval for its Generic Myocardial Perfusion Imaging Kit
Covidien Announces FDA Approval for its Generic Myocardial Perfusion Imaging Kit
HSMN NewsFeed - 30 Jun 2008
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
HSMN NewsFeed - 5 May 2008
GE Healthcare Signs Global Molecular Diagnostic Agreement to Advance Respiratory Drug Development
GE Healthcare Signs Global Molecular Diagnostic Agreement to Advance Respiratory Drug Development
HSMN NewsFeed - 1 Apr 2008
ACIST Medical Systems Enhances Portfolio with Acquisition of E-Z-EM Products and Systems
ACIST Medical Systems Enhances Portfolio with Acquisition of E-Z-EM Products and Systems
HSMN NewsFeed - 18 Mar 2008
Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
HSMN NewsFeed - 27 Feb 2008
Covidien Announces Tentative FDA Approval for Its Generic Myocardial Perfusion Imaging Kit
Covidien Announces Tentative FDA Approval for Its Generic Myocardial Perfusion Imaging Kit
HSMN NewsFeed - 20 Dec 2007
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
HSMN NewsFeed - 19 Nov 2007
Covidien Signs Contrast Imaging Agent Agreement with MedAssets Supply Chain Systems
Covidien Signs Contrast Imaging Agent Agreement with MedAssets Supply Chain Systems
HSMN NewsFeed - 15 Oct 2007
Covidien and BioSynthema Sign Exclusive Agreements for Cancer Therapy Technology
Covidien and BioSynthema Sign Exclusive Agreements for Cancer Therapy Technology
HSMN NewsFeed - 24 Jul 2007
Advanced Magnetics, Inc. Announces Name Change to AMAG Pharmaceuticals, Inc.
Advanced Magnetics, Inc. Announces Name Change to AMAG Pharmaceuticals, Inc.
HSMN NewsFeed - 4 Jun 2007
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
HSMN NewsFeed - 29 May 2007
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
HSMN NewsFeed - 16 Apr 2007
Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer
Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer
HSMN NewsFeed - 9 Apr 2007
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
HSMN NewsFeed - 19 Mar 2007
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
HSMN NewsFeed - 5 Mar 2007
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
HSMN NewsFeed - 28 Feb 2007
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
HSMN NewsFeed - 15 Feb 2007
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation
HSMN NewsFeed - 2 Feb 2007
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
HSMN NewsFeed - 4 Jan 2007
Expanded Role for Cytogen's PROSTASCINT(R) Incorporated Into NCCN(R) Clinical Practice Guidelines
Expanded Role for Cytogen's PROSTASCINT(R) Incorporated Into NCCN(R) Clinical Practice Guidelines
HSMN NewsFeed - 14 Dec 2006
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
EPIX Pharmaceuticals to File Appeal with the Center for Drug Evaluation and Research for Vasovist(TM)
HSMN NewsFeed - 31 Oct 2006
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
HSMN NewsFeed - 23 Oct 2006
FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
HSMN NewsFeed - 29 Sep 2006
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
HSMN NewsFeed - 20 Jul 2006
Berlex Issues Nationwide Recall of a Single Lot of Ultravist(R) Injection 370 mgI/mL, 125 mL in the U.S.
Berlex Issues Nationwide Recall of a Single Lot of Ultravist(R) Injection 370 mgI/mL, 125 mL in the U.S.
HSMN NewsFeed - 30 Jun 2006
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
Additional items found! 185

Members Archive contains
185 additional stories matching:
imaging agent
(Password required)
imaging agent
(Password required)